GENOVA, Inc. (9341.T) Comparison with companies in other sectors?

GENOVA, Inc. has a share price of 17.31M. You can analyze GENOVA, Inc. (9341.T) competitors across different market sectors through stock heatmaps.

What are 9341.T's NET and operating margins?

GENOVA, Inc. (9341.T) operating margin is around 0.20, and net profit margin is approximately 0.14 as of the latest reports.

In what way does 9341.T's earnings per share (EPS) trend reflect its financial momentum?

GENOVA, Inc. (9341.T) EPS is 78.99 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for GENOVA, Inc. is 8.98, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for GENOVA, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for GENOVA, Inc. like P/E which is 8.87, P/B which is 1.79, and PEG which is -0.37. Compare them with sector averages to evaluate if the stock is priced fairly.

GENOVA, Inc.

9341.T•JPX

Healthcare

Medical - Healthcare Information Services

¥719.00

¥8.00(1.13%)

Fundamental Analysis of GENOVA, Inc. (9341.T)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$78.99

P/E Ratio

8.98

ROE

0.20%

Net Margin

0.14%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$12.27B

Shares OutstandingTotal number of shares issued

$17.31M

Book Value/ShareNet worth per share

$395.96

Revenue/ShareAnnual revenue per share

$566.09

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$78.99

Net MarginNet income as percentage of revenue

14.13%

Operating MarginOperating income as percentage of revenue

20.25%

ROEReturn on shareholders' equity

20.48%

ROAReturn on total assets

16.58%

ROCEReturn on capital employed

28.79%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

$332.23

FCF YieldFree cash flow as percentage of market cap

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$10.00

Dividend YieldAnnual dividend as percentage of stock price

1.41%

Financial Ratios Analysis data is not available for 9341.TFinancial Ratios Analysis details for 9341.T are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for 9341.TSector Benchmarking details for 9341.T are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for GENOVA, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of GENOVA, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account GENOVA, Inc.'s unique business strengths and challenges.

Key Financial Metrics for GENOVA, Inc.

For GENOVA, Inc., essential financial indicators include EPS 78.99, PE 8.98, and ROE 0.20. These key ratios reveal insights into GENOVA, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare GENOVA, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of GENOVA, Inc.

Metrics like Net Margin 14.13% and ROA 16.58% shed light on how well GENOVA, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether GENOVA, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of GENOVA, Inc.

Using ratios such as P/B Ratio 1.79 and PEG Ratio -0.37, investors can assess whether GENOVA, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with GENOVA, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for GENOVA, Inc.

Financial health indicators, such as Debt/Equity Ratio 0.003 and Cash Flow -, provide a snapshot of GENOVA, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like GENOVA, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for GENOVA, Inc.

Investing in GENOVA, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at GENOVA, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;